HIV

Citations 41-50 of 103 total displayed.

Past content (since Jan 2001):

BRIEF COMMUNICATIONS
Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population

P. M. Eng, B. R. Turnbull, S. F. Cook, J. E. Davidson, T. Kurth, and J. D. Seeger
Neurology 2006; 67: 884-886. [Abstract] [Full text] [PDF]  

VIEWS & REVIEWS
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients

A. Venkataramana, C. A. Pardo, J. C. McArthur, D. A. Kerr, D. N. Irani, J. W. Griffin, P. Burger, D. S. Reich, P. A. Calabresi, and A. Nath
Neurology 2006; 67: 383-388. [Abstract] [Full text] [PDF]  

ARTICLES
Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa

N. Sacktor, N. Nakasujja, R. Skolasky, K. Robertson, M. Wong, S. Musisi, A. Ronald, and E. Katabira
Neurology 2006; 67: 311-314. [Abstract] [Full text] [PDF]  

ARTICLES
HIV neuropathy natural history cohort study: Assessment measures and risk factors

D. M. Simpson, D. Kitch, S. R. Evans, J. C. McArthur, D. M. Asmuth, B. Cohen, K. Goodkin, M. Gerschenson, Y. So, C. M. Marra, R. Diaz-Arrastia, S. Shriver, L. Millar, D. B. Clifford, and the ACTG A5117 Study Group
Neurology 2006; 66: 1679-1687. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients

Lucette A.J. Cysique, Paul Maruff, and Bruce J. Brew
Neurology 2006; 66: 1447-1450. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection

A. B. Ragin, Y. Wu, P. Storey, B. A. Cohen, R. R. Edelman, and L. G. Epstein
Neurology 2006; 66: 1255-1257. [Abstract] [Full text] [PDF]  

ARTICLES
Is skin biopsy a predictor of transition to symptomatic HIV neuropathy?: A longitudinal study

D. N. Herrmann, M. P. McDermott, J. E. Sowden, D. Henderson, S. Messing, K. Cruttenden, and G. Schifitto
Neurology 2006; 66: 857-861. [Abstract] [Full text] [PDF]  

ARTICLES
Caudate blood flow and volume are reduced in HIV⁺ neurocognitively impaired patients

B. M. Ances, A. C. Roc, J. Wang, M. Korczykowski, J. Okawa, J. Stern, J. Kim, R. Wolf, K. Lawler, D. L. Kolson, and J. A. Detre
Neurology 2006; 66: 862-866. [Abstract] [Full text] [PDF]  

ARTICLES
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort

C. L. Cherry, R. L. Skolasky, L. Lal, J. Creighton, P. Hauer, S. P. Raman, R. Moore, K. Carter, D. Thomas, G. J. Ebenezer, S. L. Wesselingh, and J. C. McArthur
Neurology 2006; 66: 867-873. [Abstract] [Full text] [PDF]  

ARTICLES
Cerebral metabolites in HIV-infected children followed for 10 months with ¹H-MRS

M. A. Keller, T. N. Venkatraman, M. A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, T. Ernst, and L. Chang
Neurology 2006; 66: 874-879. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11